日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria

CRISPR/Cas9 生成缺乏苯丙氨酸羟化酶蛋白的敲除小鼠,作为人类苯丙酮尿症的新型临床前模型

Kuldeep Singh, Cathleen S Cornell, Robert Jackson, Mostafa Kabiri, Michael Phipps, Mitul Desai, Robert Fogle, Xiaoyou Ying, Gulbenk Anarat-Cappillino, Sarah Geller, Jennifer Johnson, Errin Roberts, Katie Malley, Tim Devlin, Matthew DeRiso, Patricia Berthelette, Yao V Zhang, Susan Ryan, Srinivas Rao,

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

纳武利尤单抗单药治疗复发或转移性宫颈癌、阴道癌或外阴癌的安全性和有效性:来自 I/II 期 CheckMate 358 试验的结果

Naumann, R Wendel; Hollebecque, Antoine; Meyer, Tim; Devlin, Michael-John; Oaknin, Ana; Kerger, Joseph; López-Picazo, Jose M; Machiels, Jean-Pascal; Delord, Jean-Pierre; Evans, Thomas R J; Boni, Valentina; Calvo, Emiliano; Topalian, Suzanne L; Chen, Tian; Soumaoro, Ibrahima; Li, Bin; Gu, Junchen; Zwirtes, Ricardo; Moore, Kathleen N